The US Food and Drug Administration (FDA) has approved the first waterless cyclosporine-based solution for treating the signs and symptoms of dry eye disease, according to manufacturer Novaliq GmbH.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback